Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2019-12-24 2019-12-23
Drug Identification Number 02100606 02100606
Brand name MULTI 12 INJECTION MULTI 12 INJECTION
Common or Proper name MULTI-12 MULTI-12
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients VITAMIN B1 VITAMIN B2 BIOTIN FOLIC ACID DEXPANTHENOL PYRIDOXINE HYDROCHLORIDE NICOTINAMIDE VITAMIN C VITAMIN E VITAMIN D VITAMIN A VITAMIN B12 VITAMIN B1 VITAMIN B2 BIOTIN FOLIC ACID DEXPANTHENOL PYRIDOXINE HYDROCHLORIDE NICOTINAMIDE VITAMIN C VITAMIN E VITAMIN D VITAMIN A VITAMIN B12
Strength(s) 0.6MG 0.72MG 12MCG 80MCG 3MG 0.8MG 8MG 20MG 2UNIT 40UNIT 660UNIT 1MCG 0.6MG 0.72MG 12MCG 80MCG 3MG 0.8MG 8MG 20MG 2UNIT 40UNIT 660UNIT 1MCG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 Vials 10 Vials
ATC code B05XC B05XC
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-12-02 2019-12-02
Estimated end date 2019-12-18 2019-12-18
Actual end date 2019-12-23 2019-12-23
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Limited supply at Baxter - On allocation at 100% of historical usage Limited supply at Baxter - On allocation at 100% of historical usage
Health Canada comments